CAMPANINI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 2.802
AS - Asia 2.286
EU - Europa 2.010
SA - Sud America 399
AF - Africa 112
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.619
Nazione #
US - Stati Uniti d'America 2.731
SG - Singapore 999
CN - Cina 718
IT - Italia 593
BR - Brasile 321
IE - Irlanda 305
SE - Svezia 285
HK - Hong Kong 178
DE - Germania 141
FI - Finlandia 138
VN - Vietnam 110
GB - Regno Unito 92
NL - Olanda 88
FR - Francia 80
TR - Turchia 78
ZA - Sudafrica 74
UA - Ucraina 68
RU - Federazione Russa 56
IN - India 53
AT - Austria 51
CA - Canada 46
JP - Giappone 30
BE - Belgio 28
AR - Argentina 27
PL - Polonia 25
BD - Bangladesh 22
KR - Corea 20
CI - Costa d'Avorio 18
CO - Colombia 18
MX - Messico 18
IQ - Iraq 17
ES - Italia 14
EC - Ecuador 11
ID - Indonesia 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
RO - Romania 9
LT - Lituania 8
VE - Venezuela 8
MA - Marocco 7
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
AZ - Azerbaigian 4
EU - Europa 4
AU - Australia 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CG - Congo 2
DK - Danimarca 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
Totale 7.619
Città #
Singapore 534
Ashburn 390
Chandler 368
Dublin 305
Santa Clara 212
Dallas 209
Beijing 178
Hong Kong 177
Parma 123
Ann Arbor 116
Boardman 98
New York 83
Shanghai 82
Los Angeles 77
Hefei 74
Dearborn 71
Johannesburg 69
Jacksonville 66
Izmir 61
Nanjing 51
Princeton 48
Munich 46
Vienna 45
Ho Chi Minh City 44
Wilmington 34
São Paulo 32
Bologna 31
Moscow 28
Rio Saliceto 28
Tokyo 28
Brussels 27
Buffalo 27
Hanoi 24
Helsinki 24
Milan 23
Warsaw 23
Modena 22
San Mateo 22
Columbus 21
Toronto 21
Chicago 20
Jinan 20
Seoul 19
Woodbridge 19
Abidjan 18
Guangzhou 18
Bremen 17
Nanchang 17
Chennai 16
Houston 16
London 16
Shenyang 16
The Dalles 16
Turku 16
Hebei 15
Marseille 15
Atlanta 14
Montreal 14
Nuremberg 14
Poplar 14
Rome 14
Changsha 13
Council Bluffs 13
Kunming 13
Orem 13
Reggio Emilia 13
Sant'Ilario d'Enza 13
Bogotá 12
Des Moines 11
Jakarta 11
Stockholm 11
Amsterdam 10
Denver 10
Haiphong 10
Pune 9
San Francisco 9
Seattle 9
Sissa 9
Tianjin 9
Brasília 8
Brooklyn 8
Campinas 8
Leeds 8
Tashkent 8
Ankara 7
Bengaluru 7
Boston 7
Fairfield 7
Manchester 7
Rio de Janeiro 7
Auburn Hills 6
Baghdad 6
Bari 6
Belo Horizonte 6
Chengdu 6
Lauterbourg 6
Mumbai 6
Naples 6
Phoenix 6
Porto Alegre 6
Totale 4.626
Nome #
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 243
Lymphocyte Sub-population in Rectal Biopsies of Horses with Recurrent Colics and Malabsorption (Unhappy Hindgut Syndrome): A Preliminary Study on Morphology and Immune Microenvironment After Recovery 207
Neuroendocrine Small Cell Carcinoma of the Cervix: A case report 177
Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma 176
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 176
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 159
Immunohistochemical expression of Napsin A in normal human foetal lungs and congenital and acquired pathologic conditions 159
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 154
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 154
Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma 151
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 148
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 148
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 147
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments 146
Clinicopathological implications of the epidermal growth factor receptor, Cylooxygenase-2 expression and human papilloma virus status in squamous cell carcinoma of the uterine cervix in the elderly 141
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 141
Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions. 134
Glial transporter EAAT2 and glutamatergic turnover in humna neocortex. An immunohistochemical study 132
C-kit expression in Wilms' tumour: An immunohistochemical study 131
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 131
Immunohistochemical expression of Mesothelin in a series of high grade tubal-ovarian serous carcinoma 130
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 130
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 129
On the human amygdaloid body in normal ageing. The aminoacidergic system 126
Expression of the glial glutamate transporter EAAT2 in normal ageing 125
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 125
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 123
COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases. 121
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 121
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 118
Analysis of COX-2 expression in Wilms' Tumour. 117
Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence 117
On the myoepithelium of human salivary glands. An immunocytochemical study 115
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 115
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 114
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 113
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 113
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 110
Clinicopathological implications of the epidermal growth factor receptor, Cylooxygenase-2 expression and human papilloma virus status in squamous cell carcinoma of the uterine cervix in the elderly 109
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 109
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 108
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 107
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 107
Drug-induced glutamine depletion hinders the growth of beta- catenin mutated human liver cancer xenografts 106
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 105
Molecular classification using Lund University algorithm and clinical correlations in muscle-invasive bladder cancer: Insights from a retrospective study 101
PROGNOSTIC SIGNIFICANCE OF NM23 GENE PRODUCT EXPRESSION IN PATIENTS WITH COLORECTAL CARCINOMA TREATED WITH RADICAL INTENT 89
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 87
TUMOUR-INFILTRATING LYMPHOCYTES AND BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 87
HIF-1α expression by immunohistochemistry and mRNA-210 levels by real time polymerase chain reaction in post-mortem cardiac tissues: A pilot study 85
Gleason grading of prostate carcinoma in neddle biopsies vs. radical prostatectomy specimens 84
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 84
MYELOMA CELLS FROM THE BONE MARROW TO THE SKIN: HOW? 83
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 81
Th9 cells and allergic dermatitis 81
Histopathological lesions of the gastrointestinal tract associated with the use of polystyrene sulfonate and sevelamer: a meta-analysis 79
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 79
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 79
Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. 76
Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation 73
7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients 72
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 71
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 70
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review 61
Anticorpo monoclonale per diagnosi e trattamento di tumori canini 46
High Prognostic Value of 68Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry 46
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 44
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 28
null 20
Anticorpo biparatopico diretto verso NG2/CSPG4 e i suoi usi 16
Totale 7.790
Categoria #
all - tutte 28.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 16 52 26 57 44 33 26
2021/2022337 16 6 23 44 15 10 57 31 12 20 18 85
2022/20231.261 91 161 70 104 117 140 15 94 385 26 47 11
2023/2024609 33 56 55 37 44 134 45 33 27 34 35 76
2024/20251.857 66 82 126 121 218 213 122 80 174 202 164 289
2025/20262.336 351 336 463 415 593 178 0 0 0 0 0 0
Totale 7.790